CAS
VIVS

CTC Alternative Strategies’s VivoSim Labs VIVS Stock Holding History

CTC Alternative Strategies’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-55
Closed -$100K – 265
2014
Q1 		$100K Buy
+55
New +$128K 0.06% 129

Other funds holding VIVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CNB
City National Bank Beverly Hills, California $11.6B AUM 3.11% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

CTC Alternative Strategies's VIVS Position: Q2 2014 in Review

CTC Alternative Strategies sold out of VivoSim Labs (VIVS) in Q2 2014, closing a stake of 55 shares — an estimated $100K sold.

CTC Alternative Strategies first reported a position in VIVS in Q1 2014 and held it in 1 quarter. The position peaked at $100K in Q1 2014. 115 funds tracked by Wall St. Rank hold VIVS as of Q2 2014.

  • CTC Alternative Strategies reported no remaining VivoSim Labs position as of Q2 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 55 VivoSim Labs shares in Q2 2014, an estimated $100K.
  • CTC Alternative Strategies first reported a position in VivoSim Labs in Q1 2014 and held it in 1 quarter.
  • CTC Alternative Strategies's VivoSim Labs position peaked at $100K in Q1 2014.
  • 115 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2014.

Based on CTC Alternative Strategies's 13F filing for Q2 2014, filed 22 Jul 2014.